Angiodynamics (ANGO) Change in Cash (2010 - 2026)

Angiodynamics' Change in Cash history runs 17 years deep, the most recent figure standing at $16.1 million for Q2 2026.

• Quarterly Change in Cash rose 44.2% year-over-year to $16.1 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$2.0 million (up 89.94% YoY) and the FY2026 annual result came in at -$2.0 million, up 89.94% from the prior year.
• Change in Cash was $16.1 million for Q2 2026 at Angiodynamics, up from -$3.8 million in the prior quarter.
• Across five years, Change in Cash topped out at $17.6 million in Q1 2024 and bottomed at -$21.1 million in Q3 2024.
• A 5-year average of $1.1 million and a median of $1.6 million in 2023 frame the typical range for Change in Cash.
• Peak annual rise in Change in Cash reached 6811.42% in 2024, while the deepest fall reached 262.36% in 2024.
• Angiodynamics' Change in Cash stood at $5.3 million in 2022, then slumped by 37.46% to $3.3 million in 2023, then tumbled by 127.67% to -$916000.0 in 2024, then soared by 413.97% to $2.9 million in 2025, then soared by 458.21% to $16.1 million in 2026.
• Business Quant data shows ANGO's Change in Cash at $16.1 million in Q2 2026, -$3.8 million in Q1 2026, and $2.9 million in Q4 2025.